SmPC - Risedronate sodium Accord once a week 35 mg Film-coated Tablets: Change history
View Summary of Product Characteristics (SmPC - Risedronate sodium Accord once a week 35 mg Film-coated Tablets)
Last updated on this site: 07 Oct 2024
To update SmPC sections 2, 4.2, 4.4, 4.5, 4.7, 4.8, 5.1, 5.2 and PIL in line with reference product, Risontel Once a week 35mg film-coated Tablets (MA Number: PA0126/197/001; MAH: Clonmel; Dated: February 2021).
Additionally, SmPC section 4.8 has been updated in line with MedDRA. SmPC section 1, 4.8 and PIL have also been updated in line with QRD guidelines.
Last updated on this site: 07 Oct 2024
To update SmPC sections 2, 4.2, 4.4, 4.5, 4.7, 4.8, 5.1, 5.2 and PIL in line with reference product, Risontel Once a week 35mg film-coated Tablets (MA Number: PA0126/197/001; MAH: Clonmel; Dated: February 2021).
Additionally, SmPC section 4.8 has been updated in line with MedDRA. SmPC section 1, 4.8 and PIL have also been updated in line with QRD guidelines.
-
Changes: (Updated: 07 Oct 2024)
To update SmPC sections 2, 4.2, 4.4, 4.5, 4.7, 4.8, 5.1, 5.2 and PIL in line with reference product, Risontel Once a week 35mg film-coated Tablets (MA Number: PA0126/197/001; MAH: Clonmel; Dated: February 2021).
Additionally, SmPC section 4.8 has been updated in line with MedDRA. SmPC section 1, 4.8 and PIL have also been updated in line with QRD guidelines.
-
Changes: (Updated: 24 Apr 2023)
Website administration update
-
Changes: (Updated: 21 Sep 2022)
Initial upload